Walter Urba

Title: Walter Urba: Innovator in Immunotherapy

Introduction

Walter Urba is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of immunotherapy, particularly in enhancing the immune response of lymphocytes. His innovative approach has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Walter Urba holds a patent titled "Short-term anti-CD3 stimulation of lymphocytes to increase their in vivo immune response." This invention focuses on a method to increase the in vivo immune response of lymphocytes by stimulating them in vitro with an anti-CD3 monoclonal antibody for less than 24 hours. The process involves infusing the stimulated lymphocytes into a tumor-bearing mammal and administering IL-2. This method results in enhanced immunotherapeutic effects, such as increased cytotoxicity or lymphokine production, leading to a decrease in tumor numbers by at least 20%. He has 1 patent to his name.

Career Highlights

Walter Urba has worked with prominent organizations, including the United States of America as Represented by the Department of Health and the Regents of the University of Minnesota. His work has been instrumental in advancing research in immunotherapy and lymphocyte stimulation.

Collaborations

Throughout his career, Walter has collaborated with esteemed colleagues, including Cynthia M Loeffler and Dan L Longo. These partnerships have contributed to the development of innovative solutions in the field of immunology.

Conclusion

Walter Urba's contributions to immunotherapy through his patent and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer treatment and immune response enhancement.